Subsequently, using microarray gene expression data, they found that tumors with high expression of MSP/MT-SP1/MST1R had a significantly increased incidence of bone metastasis, and demonstrated that the overexpression of MSP pathway genes has independent prognostic value for breast cancer patients in terms of metastasis and death [128]. The gene discussed is MST1; the disease is breast cancer.